| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/JSO.23546 |
| P698 | PubMed publication ID | 24375059 |
| P50 | author | Vic J Verwaal | Q94948710 |
| P2093 | author name string | A D'Hoore | |
| A Wolthuis | |||
| S Fieuws | |||
| D Hompes | |||
| S Bruin | |||
| B Mirck | |||
| P2860 | cites work | Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy | Q44911605 |
| Systemic exposure of the parent drug oxaliplatin during hyperthermic intraperitoneal perfusion | Q46532593 | ||
| Safety and efficacy of hyperthermic intraperitoneal chemoperfusion with high-dose oxaliplatin in patients with peritoneal carcinomatosis | Q46932131 | ||
| Investigations on safety of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) with Mitomycin C. | Q51177063 | ||
| Safety monitoring of the coliseum technique for heated intraoperative intraperitoneal chemotherapy with mitomycin C. | Q53877416 | ||
| Pharmacokinetics of intraperitoneal oxaliplatin: experimental studies | Q32063412 | ||
| Randomized multicenter phase II trial of two different schedules of capecitabine plus oxaliplatin as first-line treatment in advanced colorectal cancer | Q33347194 | ||
| A phase II study of capecitabine plus oxaliplatin (XELOX): a new first-line option in metastatic colorectal cancer | Q33366181 | ||
| Mitomycin-C, 5-fluorouracil, and leucovorin as a salvage therapy in patients with metastatic colorectal adenocarcinoma | Q33393020 | ||
| Is Platinum Present in Blood and Urine from Treatment Givers during Hyperthermic Intraperitoneal Chemotherapy? | Q33988091 | ||
| Oxaliplatin-safety profile: neurotoxicity | Q35549291 | ||
| Treatment and prevention of peritoneal carcinomatosis from colorectal cancer | Q35563233 | ||
| Pharmacokinetics of intraperitoneal mitomycin C | Q35563276 | ||
| Drugs, carrier solutions and temperature in hyperthermic intraperitoneal chemotherapy. | Q37252019 | ||
| Incidence, risk factors, and impact of severe neutropenia after hyperthermic intraperitoneal mitomycin C. | Q37264971 | ||
| A comparison of hematologic toxicity profiles after heated intraperitoneal chemotherapy with oxaliplatin and mitomycin C. | Q37597149 | ||
| Curative treatment of colorectal peritoneal carcinomatosis: current status and future trends. | Q37770303 | ||
| Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study | Q39928697 | ||
| Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis. | Q40355978 | ||
| Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution | Q43910359 | ||
| Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. | Q43932503 | ||
| 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer | Q43941230 | ||
| Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy | Q44750686 | ||
| P433 | issue | 6 | |
| P921 | main subject | peritoneal carcinomatosis | Q2071182 |
| colorectal cancer | Q188874 | ||
| oxaliplatin | Q422327 | ||
| colorectal carcinoma | Q25493920 | ||
| P304 | page(s) | 527-532 | |
| P577 | publication date | 2013-12-28 | |
| P1433 | published in | Journal of Surgical Oncology | Q1919535 |
| P1476 | title | The use of Oxaliplatin or Mitomycin C in HIPEC treatment for peritoneal carcinomatosis from colorectal cancer: a comparative study | |
| P478 | volume | 109 |
| Q47553847 | A Multi-Center Randomized Trial to Evaluate Hematologic Toxicities after Hyperthermic Intraperitoneal Chemotherapy with Oxaliplatin or Mitomycin in Patients with Appendiceal Tumors |
| Q92092828 | A set of molecular markers predicts chemosensitivity to Mitomycin-C following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastasis |
| Q34477640 | Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC randomized multicentre trial |
| Q92996834 | Analysis of Bacterial and Fungal Infections after Cytoreduction Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Observational Single-Centre Study |
| Q53577988 | Cytoreductive surgery and HIPEC in treatment of colorectal peritoneal carcinomatosis: experiment or standard care? A survey among oncologic surgeons and medical oncologists. |
| Q26768309 | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a review of factors contributing to morbidity and mortality |
| Q41547533 | Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival for peritoneal carcinomatosis from colorectal cancer: a systematic review and meta-analysis of current evidence |
| Q49291015 | HIPECT4: multicentre, randomized clinical trial to evaluate safety and efficacy of Hyperthermic intra-peritoneal chemotherapy (HIPEC) with Mitomycin C used during surgery for treatment of locally advanced colorectal carcinoma |
| Q28077394 | Hyperthermic Intraperitoneal Chemotherapy and Cytoreductive Surgery in the Management of Peritoneal Carcinomatosis |
| Q92463681 | Hyperthermic intraperitoneal chemotherapy with cisplatin and mitomycin C for colorectal cancer peritoneal metastases: A systematic review of the literature |
| Q91749747 | Hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal carcinomatosis: a clinical pharmacological perspective on a surgical procedure |
| Q37178748 | Incidence of leukopenia after intraperitoneal vs combined intravenous/intraperitoneal chemotherapy in pseudomyxoma peritonei |
| Q47109168 | Inflammatory Response and Toxicity After Pressurized IntraPeritoneal Aerosol Chemotherapy. |
| Q39014341 | Intraperitoneal chemotherapy and cytoreductive surgery for peritoneal metastases coupled with curative treatment of colorectal liver metastases: an updated systematic review |
| Q41649404 | Mitomycin C Pharmacokinetics as Predictor of Severe Neutropenia in Hyperthermic Intraperitoneal Therapy. |
| Q92617992 | Neutropenia and thrombocytopenia after cytoreductive surgery and heated intraperitoneal chemotherapy |
| Q92737596 | Organoids from colorectal peritoneal metastases as a platform for improving hyperthermic intraperitoneal chemotherapy |
| Q34491336 | Oxaliplatin-based versus irinotecan-based hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal metastasis from appendiceal and colorectal cancer: a retrospective analysis |
| Q64087322 | Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parralel-group, phase II-III, r |
| Q92617940 | Pharmacological principles of intraperitoneal and bidirectional chemotherapy |
| Q53319949 | Predictors of Severe Morbidity After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Patients With Colorectal Peritoneal Carcinomatosis. |
| Q38778938 | Recommendations and consensus on the treatment of peritoneal metastases of colorectal origin: a systematic review of national and international guidelines |
| Q41682509 | Serious Postoperative Complications Affect Early Recurrence After Cytoreductive Surgery and HIPEC for Colorectal Peritoneal Carcinomatosis. |
| Q52952846 | Standard Clinical Protocol for Bidirectional Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Systemic Leucovorin, 5-Fluorouracil, and Heated Intraperitoneal Oxaliplatin in a Chloride-Containing Carrier Solution. |
| Q92716708 | Status of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer |
| Q26768405 | Surgical technology and pharmacology of hyperthermic perioperative chemotherapy |
| Q60948065 | Systematic Review of Variations in Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Metastasis from Colorectal Cancer |
| Q91856117 | The Chicago Consensus on peritoneal surface malignancies: Management of colorectal metastases |
| Q28067123 | Therapeutic options for peritoneal metastasis arising from colorectal cancer |
| Q26744031 | Treatment of peritoneal surface malignancies with hyperthermic intraperitoneal chemotherapy-current perspectives |
Search more.